Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability

Adaptive biochemical signatures

Use of plant cell membrane for the treatment of obesity

Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer

Process for the measurement of the potency of glatiramer acetate

Compositions and methods for the prevention and treatment of metabolic diseases

Use of WNT inhibitor to inhibit angiogenesis in the CNS

Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease

Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth

Methods and Compositions for Preserving the Viability of Photoreceptor Cells

Nutritional Composition for Improving the Mammalian Immune System

TREATMENT OF PULMONARY EDEMA

TREATMENT OF OBESITY

Topical drug delivery using phosphatidylcholine

Method Of Delivering Stable Topical Drug Compositions

Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent

Siglec-9 Binding Agents

NANOROD MATERIALS AND METHODS OF MAKING AND USING SAME

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

Reduced volume formulation of glatiramer acetate and methods of administration

Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation

Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes

Reduced Volume Formulation of Glatiramer Acetate and Methods of Administration

METHODS OF PREPARING PEPTIDE DERIVATIVES

Low frequency glatiramer acetate therapy

AGENTS FOR THE TREATMENT OF MULTIPLE SCLEROSIS AND METHODS OF USING SAME

Stabilized compounds having secondary structure motifs

Liquid nucleotides/nucleosides-containing product

METHODS AND COMPOSITIONS FOR THE INHIBITION OF VIRAL INFECTION BY TARGETING INTRACELLULAR TRAFFICKING

Method and compositions for prevention and treatment of diabetic and aged skin

Vaccines and compositions against

Synergistic 5′-methylthioadenosine combinations

Preparations for tissue restoration containing atrial diuretic hormone and family molecules as active ingredients; method of restoring tissue using the preparation; agents for growing, restoring, promoting growth of hair and agents for promoting restoration of skin tissue and cardiac muscle tissue containing atrial diuretic hormone family molecules as active ingredients; method of growing, restoring, promoting growth of hair by using the agents; and method of promoting restoration of skin tissue and cardiac muscle tissue

Analysis of amino acid copolymer compositions

Aminoalcohol lipidoids and uses thereof

COMPOSITIONS AND METHODS COMPRISING BASIC AMINO ACID PEPTIDES AND PROTEASES

Methods of treating disease with random copolymers

Compositions with hematopoietic and immune activity

Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances

TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE

Leukemic cell CNS infiltration controlled by notch-induced chemotaxis

15-PGDH in colon cancer

Nasal immunization

Novel antimicrobial agents

Cathepsin L mediated diseases and associated methods and products

TREATMENT OF PROLIFERATIVE DISORDERS

MODULATORS OF HYPERSENSITIVITY REACTIONS

Compositions and Methods for Treating Amyotrophic Lateral Sclerosis

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

Antigen delivery vectors and constructs

Antigen delivery vectors and constructs

Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly

Stable protein storage and stable nucleic acid storage in recoverable form

Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis

Systems for modulating inflammation

Method of treatment of age-related macular degeneration

Antimicrobial agents

Compositions and Methods for Treating or Preventing Ophthalmic Disease

ANNEXIN II COMPOSITIONS FOR TREATING OR MONITORING INFLAMMATION OR IMMUNE-MEDIATED DISORDERS

Use of Nutritional Compositions for Preventing Disorders

Calcium phosphate delivery vehicles for osteoinductive proteins

ANIMAL FEEDS AND VETERINARY COMPOSITIONS

USE OF CYSTEINE-RICH WHEY DERIVED PROTEIN IN PATIENTS RECEIVING CHEMOTHERAPY OR RADIOTHERAPY TO IMPROVE PATIENT SURVIVAL

Use of nutritional compositions for preventing disorders

TREATMENT OF ECTOPARASITIC INFESTATION

ANTIHUMAN TNF-ALPHA ANTIBODY ACTIVITY LOWERING INHIBITOR

Modified Peptides and Their Use for the Treatment of Autoimmune Diseases

USE OF PLANT CELL MEMBRANE FOR THE TREATMENT OF OBESITY

Mild composition for skin disinfection

Biological nasal bridge implant and method of manufacturing

VH4 codon signature for multiple sclerosis

COMPOSITIONS AND METHODS FOR TARGETING A POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM

Polyamides containing amino butyric acid-based building blocks

Pharmaceutical compositions and methods for peptide treatment

Capture agents and related compositions, methods and systems

Methods of inhibiting the lowering of antihuman TNF-α antibody

ANNEXIN II COMPOSITIONS FOR TREATING OR MONITORING INFLAMMATION OR IMMUNE-MEDIATED DISORDERS

COMPOSITION FOR PROVIDING A BENEFIT TO A KERATIN-CONTAINING SUBSTRATE

Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging

Methods of treating diarrhea caused by small intestinal bacterial overgrowth

Methods for treating papilloma virus infection

METHODS OF PRODUCING FUNCTIONAL MISO

Methods to identify compounds useful for the treatment of proliferative and differentiative disorders

Composition for treating cancer comprising adult stem cell culture or its fraction

Use of nucleic acids with reduced pressure therapy

Analysis of amino acid copolymer compositions

Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix

Methods of evaluating diethylamide in glatiramer acetate

SINGLEC-9 BINDING AGENTS

EXTRACELLULAR TNF INHIBITORS FOR TREATING CNS DISORDERS

Eye-drop vaccine containing copolymer 1 for therapeutic immunization

Methods of treating inflammatory airway conditions by inhibition of IL-11 activity

SOY KEFIR POWDER AND USES THEREOF

Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease

Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1

Compounds and their effects on feeding behaviour

Administration of cells and cellular extracts for rejuvenation

COMPOSITIONS COMPRISING PULMONARY SURFACTANTS AND A POLYMYXIN HAVING IMPROVED SURFACE PROPERTIES

Treatment of oropharyngeal candidiasis in cancer patients

PLATELET AGGREGATION INHIBITOR AND HEALTH FOOD EFFECTIVE IN INHIBITING PLATELET AGGREGATION

Synthetic Peptide Copolymers for Treatment and Prevention of Cardiovascular Disorders

Methods, products and uses involving platelets and/or the vasculature

TRANSDUCIBLE POLYPEPTIDES FOR MODIFYING METABOLISM

CCR3 inhibition for ocular angiogenesis and macular degeneration

Preparation and applications of novel complexes made by gamma-polyglutamic acid and cisplatin

Treatment and prevention of joint disease

Targeted contrast agents and methods for targeting contrast agents

Systems and methods of removing and managing heavy metals

Modulator of Metabolism Processes and Method of Its Receiving

Process for the measurement of the potency of glatiramer acetate

Compositions for nasal delivery

Composition and use of phyto-percolate for treatment of disease

HIGH MOLECULAR WEIGHT MEDICINE-CONTAINING PREPARATION IN POWDER FORM FOR ADMINISTRATION THROUGH MUCOSA

Combination Therapy with Triterpenoid Compounds and Proteasome Inhibitors

Methods of treating a subject suffering from irritable bowel syndrome

Self-precipitating pharmaceutical formulations for the modified release of an active principle

Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis

Methods of treatment and prevention of metabolic bone diseases and disorders

Combination therapy with co-stimulatory factors

Preparation for use of aspartate for regulating glucose levels in blood

Therapeutic Treatment of Dermatologic Skin Disorders

Combination Therapy with Glatiramer Acetate and Rasagiline for the Treatment of Multiple Sclerosis

Copolymers for suppression of autoimmune diseases, and methods of use

Overexpression of mammaglobin B in ovarian and endometrial tumors - a new diagnostic and therapeutic marker

Methods and compositions for the disruption of biofilms

IAP-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods

Methods and Compositions for Treatment of Autoimmune Diseases

Nutrient Medium for Maintaining Neural Cells in Injured Nervous System

Molecules for the treatment and prevention of fungal diseases

Composition for relieving discomfort

Methods of diagnosing and alleviating gadolinium toxicity

Methods of Treating Diabetes Using Inhibitors of ARNT2

Calcium phosphate delivery vehicles for osteoinductive proteins

PROPHYLACTIC/THERAPEUTIC AGENT FOR STRESS-INDUCED BOWEL DISEASE

Amino-acid containing composition for inhibiting accumulation of fat

AEROSOLIZED THERAPY KIT

Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies

Targeted combination immunotherapy of cancer and infectious diseases

Nutritional composition for the treatment of pressure ulcers

Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth

Methods of treating fibromyalgia caused by small intestinal bacterial overgrowth

ILK inhibitors for the treatment of renal disease

Polyamides for treating human papilloma virus

Composition containing flavan compound

Compositions and Methods Involving MDA-7 for the Treatment of Cancer

Composition for enhancing muscle recovery

Modified Fc molecules

Pharmaceutical compositions and methods for peptide treatment

Methods of treating autism and autism spectrum disorders

Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization

Combination Therapy With Glatiramer Acetate and Riluzole

Combination Therapy with Glatiramer Acetate and Minocycline for the Treatment of Multiple Sclerosis

Cat dander allergen treatments

Aldehyde-fixed platelets with internalized paramagnetic or magnetic nanoparticles

Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis

Glatiramer acetate for use as an immuno-modulatory agent

Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis

Method of treating multiple sclerosis

Microfabricated nanopore device for sustained release of therapeutic agent

Polypeptides useful for molecular weight determinations

Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

Combination therapy with glatiramer acetate and alphacalcidol for the treatment of multiple sclerosis

Kit comprising antihuman TNF-α antibody and antihuman TNF-α antibody activity lowering inhibitor

Combination drug therapy for reducing scar tissue formation

Stable topical drug delivery compositions

Liquid seasoning

Cop 1 for treatment of inflammatory bowel diseases

Methods and pharmaceutical compositions for healing wounds

Dietary products comprising one or more of γ-polyglutamic acid (γ-PGA, H form) and γ-polyglutamates for use as nutrition supplements

Compositions and methods for treating neurological disorders

Compositions with hematopoietic and immune activity

Neuronal pain pathway

Compositions and methods for targeting a polypeptide to the central nervous system

Methods of treating disease with random copolymers

Methods of treating disease with random copolymers

Treating immunological disorders using agonists of interleukin-21 / interleukin-21 receptor

Injectable non-aqueous suspension

Methods of delivering stable topical drug compositions

Mixtures of polypeptides, compositions containing and processes for preparing same, for treating neurodegenerative diseases

Protein-noble metal nanoparticles

Topical drug delivery using phosphatidylcholine

Liquid seasoning

Methods to identify compounds useful for the treatment of proliferative and differentiative disorders

Antimicrobial agents

Peptide for regulation of urokinase plasminogen activator and method of optimizing therapeutic efficacy

Use of stable glutamine derivatives to improve drug absorption

Methods of treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth

Stable protein storage and stable nucleic acid storage in recoverable form

Antigen delivery vectors and constructs

Techniques to treat neurological disorders by enhancing the presence of anti-inflammatory mediators

Stabilized compounds having secondary structure motifs

Delivery of compounds with rehydrated blood cells

High molecular weight medicine-containing preparation in powder form for administration through mucosa

Combinatorial methods and compositions for treatment of melanoma

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

Composition for relieving discomfort

Pharmaceutical compositions and methods for peptide treatment

Method of transporting physiological polymer using protein having rxp repeated sequence

Nutrient Medium for maintaining neural cells in injured nervous system

Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties

Extracellular TNF inhibitors for treating CNS disorders

JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection

Tumor necrosis factor combined with interferon in demyelinating diseases

Nutritional composition for the treatment of pressure ulcers

Methods for preserving the viability of photoreceptor cells by anti-FAS-ligand/anti-FAS-receptor antibodies

Ilk inhibitors for the treatment of renal disease

Compositions and methods for targeting a polypeptide to the central nervous system

Helicobacter pylori adhesion inhibitor

Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators

Inhibitors of PACE4 for the treatment of arthritis

Combination drug therapy for reducing scar tissue formation

Immunogenic cancer peptides and uses thereof

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

Fixed-dried platelets cross-linked to protein

Sunburn treatment and sunburn prevention method

Treatment of central nervous system diseases by antibodies against glatiramer acetate

Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders

Method of diagnosing fibromyalgia caused by small intestinal bacterial overgrowth

Composition for treating or preventing insulin resistance

UV therapy protocol for treatment of non-dermatological autoimmune conditions

ROS-responsive liposomes for specific targeting

GHB formulation and method for its manufacture

GHB formulation and method for its manufacture

ROS-responsive liposomes for specific targeting

Polybasic antimalarial agents and methods of use thereof

N-amino peptide beta-sheet mimics for the treatment of Alzheimer's disease

ROS—responsive liposomes for specific targeting

Methods for systemically delivering polypeptides and microorganisms therefor

Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvenation

Composition and method for treating skin conditions

GHB formulation and method for its manufacture

Methods and compositions using AMPK activators for pharmacological prevention of chronic pain

Process for manufacturing glatiramer acetate product

Nano-encapsulated, controlled drug manufacturing process

Plasmonics-active metal nanostar compositions and methods of use